📌 Key Takeaways
- Topic: Silica Supplier Vietnam: Market Overview and Sourcing Options
- Keywords: silica free flow agent
- Published: 2026-11-20 07:21:45
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Production Process: Step-by-Step Guide for Fumed, Precipitated and Fused Silica
- Silica Supplier Turkey: Market Overview, Producers and Import Options
- Fumed Silica Manufacturer: Production Process, Key Grades and How to Choose
- 13. Lamson N.G., Berger A., Fein K.C., Whitehead K.A. Anionic nanoparticles enable the oral delivery of proteins by improving intestinal permeability. Nat. Biomed. Eng. 2020;4:84-96. doi: 10.1038/s41551-019-0465-5. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Polysilicon vs Silica: From Quartz Sand to Solar-Grade Silicon
- What Is Fused Silica Sand? Properties and Uses in Investment Casting and Refractories
- Several recent research works can support the prior finding and show that APIs in MSNs sustain their chemical structure, unaffected by covalent bonding during adsorption, storage, or release. Porras et al. observed consistent FTIR peaks for drug-MSN systems (albendazole loaded into SBA-15), confirming the preservation of functional groups [ 50 ]. Ditzinger et al. attained the stabilization of haloperidol and carbamazepine in their amorphous forms through adsorption into mesoporous silica, sustaining their chemical integrity [ 51 ]. PXRD and DSC analyses confirmed that the drugs remained amorphous post-incorporation without recrystallization for at a minimum three months. Particularly, the absence of new PXRD peaks and DSC melting endotherms during this period signals there is no chemical degradation or alteration of the chemical structure [ 51 ]. Minecka et al. demonstrated that while aripiprazole transforms from crystalline to amorphous form upon adsorption into mesoporous silica, the chemical structure of the API remains unchanged [ 52 ]. To track the molecular state of the drug during and after amorphization, calorimetric, X-ray diffraction, and dielectric methods were carried out by the researchers to provide proof. The findings recommend that the steric hindrance impact averts recrystallization, consequently preserving chemical structures as amorphous APIs revert to the original form [ 52 ]. Knapik-Kowalczuk et al. found that celecoxib in Syloid 244FP exhibits stable FTIR and NMR signals and intact molecular dynamics after amorphization, showing stabilization via physical interactions (steric hindrance and surface interactions without extra bond formation) [ 53 ]. Richter et al. converted itraconazole to an amorphous form in the presence of mesoporous silica, without altering its chemical structure, by the twin-screw extrusion method, as confirmed by consistent thermal and diffraction analyses [ 54 ]. Furthermore, Antonino et al. highlighted the transition of naproxen and ibuprofen from crystalline to amorphous when they were adsorbed into mesoporous silica (Syloid 72FP) [ 55 ]. This change is purely physical, with no chemical alterations to the drug molecules. Approaches such as differential scanning calorimetry (DSC), X-ray diffraction (XRPD), and solid-state NMR verify that the APIs' chemical structure of the APIs remains intact throughout and after amorphization. Drug adsorption onto the silica surface creates a stabilized amorphous state that resists recrystallization without changing the chemical bonds of the APIs. This stabilization stems from physical confinement and interactions such as hydrogen bonding or van der Waals forces with the silica, without any chemical reactions or degradation [ 55 ]. In summary, MSNs accomplish API amorphization and stabilization through steric confinement and non-covalent adsorption, thereby preserving chemical structures, as verified by consistent data obtained by researchers.
Crystalline Silica Dust Hazard: Health Risks and How to Protect Workers
What is silica (SiO₂)?
silica powder Malaysia
What is the difference between fumed silica and precipitated silica?
silicon dioxide manufacturer
What drives silica raw material prices?
mesoporous silica One of the biggest challenges of tableting greatly potent APIs (antibiotics, hormones, cytostatic molecules) is to attain content uniformity [ 95, 96 ]. Since these molecules are used in small doses, it is demanding to attain a homogeneous powder mixture during mixing and to make sure this homogeneity until the end of tableting. Also, it is a hurdle to develop a reproducible method that ensures content uniformity for each production batch, since the specified dose must be made sure between batches, not just within one batch [ 95, 96 ]. A reliable alternative method is to use mesoporous silica as a carrier system rather than simple powder mixing, thus preventing the segregation and aggregation of the low-dose API during mixing and compression. In this case, the preloaded mesoporous carrier and the necessary excipients are mixed, and then the powder mixture can be compressed directly or after granulation. The drug loading can be controlled by the concentration of the drug solution used to fill the carrier systems, which affects the amount of the drug content in the concluding medicine [ 95, 96 ]. Based on this, nearly unlimitedly low doses can be formulated into tablets, even in a concentration of 0.01%, just by properly preparing the solution [ 96 ]. The technique is well-controllable and dependable, since each tablet has the same drug content and the desired content uniformity. Furthermore, the method can be used in both batch-based and continuous production [ 96 ]. This may be a promising finding because there is evidence that it is challenging to move from batch-based to continuous manufacturing while maintaining the desired drug content and content uniformity [ 94 ]. But it should be noted that in this study, no nanocarrier system was used [ 94 ], so utilizing MSN formulations could make an enormous improvement in developing continuous tablet manufacturing [ 96 ]. A study shown that MSN carriers can also be used in orodispersible films to enhance the dissolution of poorly water-soluble drugs [ 100 ]. Based on in vitro drug release studies, more than 90% of prednisolone was released within 2 min when the loaded MSN was incorporated into the formulation. This means a much faster, immediate release in comparison with formulations containing the free form of the drug. In addition, precise dosing can be accomplished utilizing nanocarriers for personalized medication; furthermore, enabling the production of low-dose preparations without content uniformity problems [ 100 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.